#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fibrous dysplasia of bone Penile cancer Fatty acid oxidation disorder Lip and/or oral cavity cancer Hepatitis B Chronic lymphocytic leukaemia recurrent Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Spinal cord injury cervical Turner's syndrome Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Angiosarcoma non-metastatic PIK3CA related overgrowth spectrum Epilepsy Paroxysmal nocturnal haemoglobinuria HER2 mutant non-small cell lung cancer More trials…

    Learn about Rare Diseases

    Chondrosarcoma metastatic – Treatment Activated PI3 kinase delta syndrome – Trials in Disease Prader-Willi syndrome Waldenstrom’s macroglobulinaemia refractory Chordoma – Trials in Disease Hereditary angioedema – Treatment Waldenstrom’s macroglobulinaemia refractory – Diagnostics Primary immunodeficiency syndrome – Treatment Rhabdomyosarcoma – Life with Disease Factor IX deficiency – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Desonide Filgotinib Dc-806 Argatroban Monohydrate Lbl-007 Olopatadine Cilastatin NORETHISTERONE ACETATE MAPLIRPACEPT Daxdilimab Melphalan Hydrochloride Prilocaine Iclepertin Pyruvic Acid Asciminib Vixarelimab Talazoparib Neomycin Sulfate Simvastatin Ep0031 More therapies…

    Learn about Your Condition

    Persistent depressive disorder Impaired gastric emptying Eclampsia Bronchostenosis Mast cell activation syndrome Pulmonary alveolar haemorrhage Skin ulcer Acute hepatic failure Mucosal inflammation Pain in extremity Spinal cord injury Amyloidosis Thrombolysis Arterial disorder Dry mouth More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Universitaetsklinikum Knappschaftskrankenhaus Bochum…

Universitaetsklinikum Knappschaftskrankenhaus Bochum GmbH

In Der Schornau 23-25, Langendreer, Bochum, 44892, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Adding Isatuximab to Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Isatuximab
    • Bortezomib
    • Dexamethasone
    Germany

  • Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Gilteritinib
    • Midostaurin
    Austria Belgium Finland France Germany Ireland +5

  • Study on Atezolizumab with Drug Combination for Patients with Gastric Cancer and Esophagogastric Junction Adenocarcinoma

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Calcium Folinate Pentahydrate
    • Docetaxel
    Germany

  • Study on the Effectiveness and Safety of a Vaccine with Dendritic Cells for Patients with Newly Diagnosed Glioblastoma

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Autologous Mature Dendritic Cells Loaded With Autologous Tumor Lysate
    Germany

  • Study Comparing Short Course Radiotherapy and Chemoradiotherapy with Fluorouracil, Calcium Folinate, and Capecitabine for Intermediate and High-Risk Rectal Cancer Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Calcium Folinate Pentahydrate
    • Capecitabine
    • Fluorouracil
    Germany

  • Study on Epirubicin and Sodium Chloride for Patients with Sepsis or Septic Shock in Intensive Care Units

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Septic shock
    • Sepsis
    Investigated Drugs:
    • Epirubicin Hydrochloride
    • Sodium Chloride
    Germany

  • Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Bleomycin Sulfate
    • Brentuximab Vedotin
    • Dacarbazine
    Austria Denmark Germany The Netherlands Norway Sweden

  • Study of Rituximab, Polatuzumab Vedotin, and Glofitamab for Untreated Aggressive B-cell Lymphoma in Patients Over 60 Not Eligible for Full R-CHOP

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    Investigated Drugs:
    • Polatuzumab Vedotin
    • Glofitamab
    • Obinutuzumab
    Austria Germany

  • Study of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation

    Not recruiting

    3 1
    Investigated Drugs:
    • Enasidenib Mesilate
    • Ivosidenib
    Austria Belgium Estonia Finland France Germany +6

  • Study Comparing Standard Chemotherapy with CPX-351 for Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) and Intermediate or Adverse Genetics

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Daunorubicin
    • Cytarabine
    Austria Germany
Previous Page
1 2 3 4
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!